PPARA and Alzheimer disease: Some early research reported an association of the PPARα L162V polymorphism with AD risk (91), whereas recently the expression and transcriptional activity of PPARα have been found to correlate with the expression of hAPP (8), which is thought to be one of the main causes of AD.